Multisensory Fusion Training and 7, 8-Dihydroxyflavone Improve Amyloid-β-Induced Cognitive Impairment, Anxiety, and Depression-Like Behavior in Mice Through Multiple Mechanisms
DOI: https://doi.org/10.2147/ndt.s459891
IF: 2.989
2024-06-13
Neuropsychiatric Disease and Treatment
Abstract:Jiejie Guo, 1– 3 Yanzi Cao, 1 Ting Zhang, 2 Chunshuang Xu, 1 Zhitao Liu, 1, 4 Wanyi Li, 1 Qinwen Wang 1 1 Zhejiang Key Laboratory of Pathophysiology, NBU Health Science Center, Ningbo University, Ningbo, People's Republic of China; 2 Department of Clinical Laboratory, The First People's Hospital of Wenling, Taizhou, People's Republic of China; 3 Department of Neurology, The First People's Hospital of Wenling, Taizhou, People's Republic of China; 4 Fujian Normal University, Fuzhou, People's Republic of China Correspondence: Qinwen Wang, Zhejiang Key Laboratory of Pathophysiology, NBU Health Science Center Ningbo University, Ningbo, People's Republic of China, Email Background: There is growing interest in the role of physical activity in patients with of Alzheimer's disease (AD), particularly regarding its impact of cognitive function, gut microbiota, metabolites, and neurotrophic factors. Objective: To investigate the impact of multisensory fusion training (MSFT) combined with 7, 8-dihydroxyflavone (DHF) on the behavioral characteristics, protein expression, microbiome, and serum metabolome using the AD model in mice induced with amyloid-β (Aβ). Methods: We assessed cognitive ability, anxiety-like and depression-like behaviors in Aβ mice using behavioral measures. Western blotting was employed to detect the expression of relevant proteins. The 16S rRNA gene sequencing and metabolomics were used to analyze changes in the intestinal microbial composition and serum metabolic profile, respectively, of Aβ mice. Results: The behavioral outcomes indicated that a 4-week intervention combining DHF and MSFT yielded remarkable improvements in cognitive function and reduced anxiety and depression-like behaviors in Aβ mice. In the hippocampus of Aβ mice, the combined intervention increased the levels of BDNF, VGF, PSD-95, Nrf2, p-GSK3β and p-CREB proteins. Analyses of sequence and metabolomic data revealed that Bacteroides and Ruminococcaceae were remarkably more abundant following the combined intervention, influencing the expression of specific metabolites directly linked to the maintenance of neuronal and neurobehavioral functions. These metabolites play a crucial role in vital processes, such as amino acid metabolism, lipid metabolism, and neurotransmitter metabolism in mice. Conclusion: Our study highlighted that MSFT combined with DHF improves cognitive impairment, anxiety, and depression-like behavior in Aβ mice through multiple mechanisms, and further validated the correlation between the gut microbiome and serum metabolome. These findings open up a promising avenue for future investigations into potential treatment strategies for AD. Keywords: Alzheimer's disease, brain-derived neurotrophic factor, cognitive impairment, acousto-optic stimulation, treadmill exercise Alzheimer's disease (AD) is a leading neurodegenerative condition predominantly affecting older adults, leading to memory loss, cognitive decline, and behavioral challenges. 1–3 Currently, the number of individuals with AD worldwide is approximately 50 million, with projections indicating that this might triple by 2050. 4 Clinical manifestations of AD include declining memory, cognitive impairment, language difficulties, and reduced learning abilities. 5 AD is characterized by the formation of senile plaques, composed of extracellular amyloid-β (Aβ) oligomers, and the accumulation of hyperphosphorylated tau proteins, leading to the formation of intracellular neurofibrillary tangles. 6,7 The primary pharmacological therapies for AD involve the use of acetylcholinesterase (AChE) inhibitors, such as donepezil, rivastigmine, and galantamine, along with memantine, an antagonist targeting the excitatory amino acid receptor. 8 While drug therapy remains the mainstream approach for AD treatment, it only offers temporary relief of symptoms and cannot reverse the underlying pathological processes; furthermore, it often has significant side effects in the older population. 9 However, available therapeutic options for AD are limited. Studies have shown that adult neurogenesis can be enhanced through different approaches, such as the use of drugs, engaging in physical activity, and exposure to stimulating environments. 10,11 These interventions have demonstrated encouraging outcomes in improving cognitive abilities and decreasing Alzheimer's disease pathologies in animal models. However, the effectiveness of a singular treatment approach remains limited. 12 Growing evidence suggests that exercise interventions can reduce Aβ deposition, enhance neural plasticit -Abstract Truncated-
psychiatry,clinical neurology